Skip to main content

Diabetes, Type 2 News

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity

THURSDAY, Sept. 18, 2025 – In adults with obesity and those with type 2 diabetes and obesity, once-weekly semaglutide 7.2 mg is superior to placebo for body weight reduction, according to two...

Ozempic, Zepbound Offer Unexpected Benefits For Psoriasis Patients

THURSDAY, Sept. 18, 2025 — People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says. Psoriasis patients taking GLP-1 d...

FDA Cracks Down on Hims, Other Telehealth Companies Over Drug Ads

WEDNESDAY, Sept. 17, 2025 — Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications. On Tu...

Hair Samples May Help Spot Mental Health Risks in Sick Kids

WEDNESDAY, Sept. 17 2025 — Children with chronic illnesses face extra challenges, and measuring stress through hair samples may help doctors predict which kids are at highest risk for mental health p...

Weight-Loss Surgery Bests Medical Weight Management for Obesity-Related Risk Mitigation

WEDNESDAY, Sept. 17, 2025 – Bariatric surgery is associated with a significantly lower risk for developing major metabolic comorbidities compared with a medical weight management program for adults...

Smoking Tied to Increased Risk for Type 2 Diabetes

WEDNESDAY, Sept. 17, 2025 -- Smoking increases the risk for type 2 diabetes across all disease subtypes, according to a study presented at the annual meeting of the European Association for the Study ...

Can Weed Increase Risk Of Type 2 Diabetes?

TUESDAY, Sept. 16, 2025 — Weed might nearly quadruple a person’s risk of developing type 2 diabetes, a new study says. People who use cannabis have a 3.7 times greater risk of type 2 diabetes com...

Smoking Increases Risk Of Type 2 Diabetes

MONDAY, Sept. 15, 2025 — Smokers have a higher risk of developing type 2 diabetes, especially if they are genetically predisposed to the condition, a new study says. People who ever smoked at all h...

Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment

MONDAY, Sept. 15, 2025 – In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study published online Sept. 8...

Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year

MONDAY, Sept. 15, 2025 — Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. About 52% of people in Denmark prescribed semaglutide (Ozempic, W...

Hepatitis B Virus Immunity Linked to Reduced Risk for Diabetes

THURSDAY, Sept. 11, 2025 – Hepatitis B virus (HBV) immunity in individuals without HBV infection is associated with a reduced risk for diabetes, according to a study published online June 25 in...

Nearly Half Of People With Diabetes Unaware Of Their Illness

WEDNESDAY, Sept. 10, 2025 — Nearly half of people with diabetes around the world are unaware of their condition, according to a new study. Globally, an estimated 44% of people 15 and older with d...

WHO Updates List of Essential Medicines to Include GLP-1s

TUESDAY, Sept. 9, 2025 – The World Health Organization published updated editions of its Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc) to include new treatments...

FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

FRIDAY, Sept. 5, 2025 -- The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering ...

Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation

THURSDAY, Sept. 4, 2025 – Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control, but also faster progression to severe diabetes and a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N